Safety and efficacy of eblasakimab, an IL-13R alpha 1 monoclonal antibody, in adults with moderate-to-severe atopic dermatitis: a phase 1b, multiple-ascending dose study. Supplementary information.
收藏NIAID Data Ecosystem2026-05-01 收录
官方服务：
资源简介：
This dataset contains figures, tables, and documents referenced in: Safety and efficacy of eblasakimab, an IL-13R alpha 1 monoclonal antibody, in adults with moderate-to-severe atopic dermatitis: a phase 1b, multiple-ascending dose study. (Blauvelt et al.)
创建时间：
2023-10-16
